Showing results (81-90 of 136) with videos related to
Sort By:
Pageof 14
Annals of the Rheumatic Diseases|March 25, 2016
Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled studyMunther Khamashta, Joan T Merrill, Victoria P Werth, et al.Arthritis and Rheumatism|June 28, 2006
Abnormal differentiation of memory T cells in systemic lupus erythematosusRuth D Fritsch, Xinglei Shen, Gabor G Illei, et al.Urology|July 22, 1998
Effect of simulated birth trauma on the urinary continence mechanism in the ratA S Lin, S Carrier, D M Morgan, et al.Arthritis and Rheumatism|January 30, 2010
Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation studyGabor G Illei, Yuko Shirota, Cheryl H Yarboro, et al.Immunology Letters|July 1, 1989
Different types of false positive anti-HIV reactions in patients on haemodialysisE Ujhelyi, G Füst, G Illei, et al.Immunity|November 6, 2012
Interleukin-17 cytokines are critical in development of fatal lupus glomerulonephritisPrapaporn Pisitkun, Hye-Lin Ha, Hongshan Wang, et al.Arthritis & Rheumatology (Hoboken, N.J.)|January 29, 2017
Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus ErythematosusRichard Furie, Munther Khamashta, Joan T Merrill, et al.The Journal of Gene Medicine|November 27, 2009
Transient detection of E1-containing adenovirus in saliva after the delivery of a first-generation adenoviral vector to human parotid glandChangyu Zheng, Nikolay P Nikolov, Ilias Alevizos, et al.Biochemistry|November 14, 2001
A designed Zn2+-binding amphiphilic polypeptide: energetic consequences of pi-helicityD M Morgan, D G Lynn, H Miller-Auer, et al.Endocrinology|January 14, 1999
Differential regulation of gene transcription in subpopulations of human B lymphocytes by vitamin D3J W Morgan, D J Sliney, D M Morgan, et al.Pageof 14